In March, Barfresh raised about $7.5 million by selling convertible notes to accredited investors, using part of the proceeds to repay a mortgage. Seven months later, the dairy facility at the center of its production still needs about $5.1 million more to finish.
Shares closed 18.53% higher at $0.7700, on dollar volume of about $2 million.
The third-quarter filing says the remaining cost to complete the Arps Dairy expansion is about $5.1 million, net of a USDA grant worth about $2.5 million. That grant has a hard deadline: all funded phases must be complete and the money spent by April 30, 2027, or the company may have to repay it. Miss that deadline and the remaining bill rises to about $7.5 million. The original deadline was December 31, 2026; the company says it obtained an extension.
The March notes carry 10% annual interest and can be converted into shares at $2.90 each. At the end of September, the balance sheet showed $247,000 in cash and $7,064,000 in convertible notes. The company used about $3.6 million in operating cash in the first nine months of the year.
The facility is not optional. By the third quarter, Arps Dairy was handling 91% of the company's legacy production, a shift that became necessary after one outside manufacturer discontinued its products in December 2025 and a second's contract concluded in February 2026. The filing says that if the facility cannot be completed, the company would face significant uncertainty about its ability to supply products at all.